Sulfatide and GM1 ganglioside modulate the high-affinity dopamine uptake in rat striatal synaptosomes: Evidence for the involvement of their ionic charges

Neurochemistry International

Volumn 42, Issue 4, 2003, Pages 305-313

  Barrier, Laurence ^a,b   Page, Guylène ^a   Barc, Stéphanie ^a   Piriou, Alain ^a,b   Portoukalian, Jacques ^c  

^a UPRES EA 1223   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Dopamine uptake; Ganglioside; Rat brain; Sulfatide; Synaptosomes

Indexed keywords

ALCOHOL; DOPAMINE; DOPAMINE TRANSPORTER; FUNCTIONAL GROUP; GALACTOSYLCERAMIDE; GANGLIOSIDE GM1; GLYCOLIPID; SULFATIDE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE UPTAKE; IONIC STRENGTH; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AUTORADIOGRAPHY; CHROMATOGRAPHY, THIN LAYER; DOPAMINE; G(M1) GANGLIOSIDE; GLYCOLIPIDS; IONS; KINETICS; MALE; NEOSTRIATUM; RATS; RATS, WISTAR; SULFOGLYCOSPHINGOLIPIDS; SYNAPTOSOMES; TRYPSIN;

EID: 0037333020     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00103-1     Document Type: Article

References (57)

1. Abe T., Norton W.T. The characterization of sphingolipids from neurons and astroglia of immature rat brain. J. Neurochem. 23:1974;1025-1036.
2. Amara S., Kuhar M. Neurotransmitter transporters: recent progress. Ann. Rev. Neurosci. 16:1993;73-93.
3. Anand J.K., Sadozai K.K., Hakomori S. A simple method for the synthesis of ceramides and radiolabeled analogues. Lipids. 9:1996;995-998.
4. Barc S., Page G., Fauconneau B., Barrier L., Huguet F. A new in vitro approach for investigating the MPTP effect on DA uptake. Neurochem. Int. 38:2001;243-248.
5. Barrier L., Barrier J., Arnaud M., Piriou A., Tallineau C. Alterations in the ganglioside composition of rat cortical brain slices during experimental lactic acidosis: implication of an enzymatic process independent of the oxidative stress. Biochim. Biophys. Acta. 1336:1997;15-22.
6. Bassi R., Chigorno V., Fiorelli A., Sonnino S., Tettamanti G. Exogenous gangliosides GD1b and GD1b-lactone, stably associated to rat brain P2 subcellular fraction, modulate differently the process of protein phosphorylation. J. Neurochem. 57:1991;1207-1211.
7. Berfield J.L., Wang L.C., Reith M.E.A. Which form of dopamine is the substrate for the human dopamine transporter: the cationic or the uncharged species? J. Biol. Chem. 274:1999;4876-4882.
8. Bouchon B., Portoukalian J., Madec A.M., Orgiazzi J. Evidence for several cell populations in human thyroid with distinct glycosphingolipid patterns. Biochim. Biophys. Acta. 1051:1990;1-5.
9. Cumar F.A., Maggio B., Caputo R. Neurotransmitter movements in nerve endings. Influence of substances that modify the interfacial potential. Biochim. Biophys. Acta. 597:1980;174-182.
10. +. J. Neurosci. 13:1993;3104-3111.
11. Facci L., Leon A., Toffano G., Sonnino S., Ghidoni R., Tettamanti G. Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and the cell association of ganglioside GM1. J. Neurochem. 42:1984;299-305.
12. Faro L.R., do Nascimento J.L., Alfonso M., Duran R. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter. Neurochem. Int. 40:2002;455-465.
13. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
14. Glowinski J., Iversen L.L. Regional studies of catecholamines in rat brain. J. Neurochem. 13:1966;655-663.
15. Hadjiconstantinou M., Neff N.H. GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems. J. Neurochem. 70:1998;1335-1345.
16. m in enzyme reactions. Science. 116:1952;329-331.
17. Inazu M., Kubota N., Takeda H., Oguchi K., Koizumi M., Kimura S., Matsumiya T. Methyl-4-phenylpyridinium (MPP(+))-evoked dopamine release from rat striatal slices: possible roles of voltage-dependent calcium channels and reverse dopamine transport. Neurochem. Int. 39:2001;253-260.
18. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 36:1997;245-319.
19. Jaber M., Jones S., Giros B., Caron M.G. The dopamine transporter: a crucial component regulating dopamine transmission. Movement Disorders. 12:1997;629-633.
20. 3H ] arachidonic acid from blood into rat brain synaptosomal fractions before and after cholinergic stimulation J. Neurochem. 67:1996;822-829.
21. +)-ATPase by nanomolar concentrations of GM1 ganglioside. J. Neurochem. 37:1981;350-357.
22. Leon A., Dal Toso R., Presti D., Benvegnù D., Facci L., Kirschner G., Tettamanti G., Toffano G. Development and survival of neurons in dissociated fetal mesencephalic serum-free cultures. II. Modulatory effects of gangliosides. J. Neurosci. 8:1988;746-753.
23. Lesch K.P., Bengel D. Neurotransmitter reuptake mechanisms. Pharmacol. Pathophysiol. CNS Drugs. 4:1995;302-322.
24. Leviel V. The reverse transport of DA, what physiological significance? Neurochem. Int. 38:2001;83-106.
25. Masserini M., Palestini P., Pitto M., Chigorno V., Tomasi M., Tettamanti G. Cyclic AMP accumulation in HeLa cells induced by cholera toxin. Involvement of the ceramide moiety of GM1 ganglioside. Biochem. J. 271:1990;107-111.
26. Miettinen T., Takki-Luukkainen I.T. Use of butyl acetate in determination of sialic acid. Acta Chim. Scand. 13:1959;856-858.
27. Near J.A., Bigelow J.C., Wightman R.M. Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J. Pharmacol. Exp. Therapeutics. 245:1988;921-927.
28. Nicholls D.G. The glutamatergic nerve terminal. Eur. J. Biochem. 212:1993;613-631.
29. Palestini P., Pitto M., Tedeschi G., Ferraretto A., Parenti M., Brunner J., Masserini M. Tubulin anchoring to glycolipid-enriched, detergent-resistant domains of the neuronal plasma membrane. J. Biol. Chem. 275:2000;9978-9985.
30. Pepeu, G., Oderfeld-Nowak, B., Casamenti, F., 1994. CNS pharmacology of gangliosides. In: Svennerholm, L., Asbury, A.K., Reisfeld, R.A., Sandhoff, K., Suzuki, K., Tettamanti, G., Toffano, G. (Eds.), Progress in Brain Research, Vol. 101. Elsevier, Amsterdam, pp. 327-335.
31. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83:1977;346-356.
32. Pitto M., Palestini P., Ferraretto A., Flati S., Pavan A., Ravasi D., Masserini M., Bottiroli G. Dynamics of glycolipid domains in the plasma membrane of living cultured neurons, following protein kinase C activation: a study performed by excimer-formation imaging. Biochem. J. 344:1999;177-184.
33. 2+-ganglioside-interaction in neuronal differentiation and development. In: Svennerholm, L., Asbury, A.K., Reisfeld, R.A., Sandhoff, K., Suzuki, K., Tettamanti, G., Toffano, G. (Eds.), Progress in Brain Research, Vol. 101. Elsevier, Amsterdam, pp. 127-145.
34. Raiteri M., Versace P., Marchi M. GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion. Eur. J. Pharmacol. 118:1985;347-350.
35. 14C ) aminosugar-containing glycosphingolipids by de-N-acetylation and re-N-acetylation Biochim. Biophys. Acta. 1244:1995;418-422.
36. Riboni L., Viani P., Bassi R., Prinetti A., Tettamanti G. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:1997;153-195.
37. Saqr H.E., Pearl D.K., Yates A.J. A review and predictive models of ganglioside uptake by biological membranes. J. Neurochem. 61:1993;395-411.
38. Schneider J.S. MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment. J. Neurosci. Res. 31:1992;112-119.
39. Schwarzmann G., Hoffmann-Bleihauer P., Schubert J., Sandhoff K., Marsh D. Incorporation of ganglioside analogues into fibroblast cell membranes. A spin-label study. Biochemistry. 22:1983;5041-5048.
40. Sonnino S., Chigorno V., Acquotti D., Pitto M., Kirschner G., Tettamanti G. A photoreactive derivative of radiolabeled GM1 ganglioside: preparation and use to establish the involvement of specific proteins in GM1 uptake by human fibroblasts. Biochemistry. 28:1989;77-84.
41. Svennerholm L. Quantitative estimation of sialic acid. II. A colorimetric resorcinol-hydrochloric acid method. Biochim. Biophys. Acta. 24:1957;604-611.
42. Svennerholm L. Ganglioside designation. Adv. Exp. Med. Biol. 125:1980;11.
43. 2+ influx and acetylcholine release in brain synaptosomes. Neuroreport. 8:1997;2203-2207.
44. Tettamanti, G., Riboni, L., 1994. Gangliosides turnover and neural function: A new perspective. In: Svennerholm, L., Asbury, A.K., Reisfeld, R.A., Sandhoff, K., Suzuki, K., Tettamanti, G., Toffano, G. (Eds.), Progress in Brain Research, Vol. 101. Elsevier, Amsterdam, pp. 77-100.
45. Thomas P.D., Brewer G.J. Gangliosides and synaptic transmission. Biochim. Biophys. Acta. 1031:1990;273-289.
46. Toffano G., Benvegnù D., Bonetti A.C., Facci L., Leon A., Orlando P., Ghidoni R., Tettamanti G. Interactions of GM1 ganglioside with crude rat brain neuronal membranes. J. Neurochem. 35:1980;861-866.
47. Vaughan, R.A., 2000. Regulation of dopamine transporter by phosphorylation and impact on cocaine action. In: Reith, M.E.A. (Ed.), Cerebral Signal Transduction: From First to Fourth Messengers. Humana Press, Totowa, NJ, pp. 374-399.
48. Vos J.P., Lopez-Cardozo M., Gadella B.M. Metabolic and functional aspects of sulfogalactolipids. Biochim. Biophys. Acta. 1211:1994;125-149.
49. Wiegandt, H., 1985. Gangliosides. In: Wiegandt, H. (Ed.), New Comprehensive Biochemistry: Glycolipids, Vol. 10. Elsevier, Amsterdam, pp. 199-260.
50. Wieraszko A., Seifert W. Evidence for a functional role of gangliosides in synaptic transmission: studies on rat brain striatal slices. Neurosci. Lett. 52:1984;123-128.
51. Wieraszko A., Seifert W. The role of monosialoganglioside GM1 in the synaptic plasticity: in vitro study on rat hippocampal slices. Brain Res. 345:1985;159-164.
52. Wieraszko A., Seifert W. Evidence for the functional role of monosialoganglioside GM1 in synaptic transmission in the rat hippocampus. Brain Res. 371:1986;305-313.
53. Wu, G., Ledeen, R.W., 1994. Gangliosides as modulators of neuronal calcium. In: Svennerholm, L., Asbury, A.K., Reisfeld, R.A., Sandhoff, K., Suzuki, K., Tettamanti, G., Toffano, G. (Eds.), Progress in Brain Research, Vol. 101. Elsevier, Amsterdam, pp. 101-112.
54. Young H.P., Christian Z.F., Cabeza R., Irwin L. Uptake of exogenous gangliosides by rat brain synaptosomes. Neurochem. Res. 23:1998;1515-1520.
55. Yu, R.K., Saito, M., 1989. Structure and localization of gangliosides. In: Margolis, R.U., Margolis, R.K. (Eds.), Neurobiology of Glycoconjugates. Plenum Press, New York, pp. 1-42.
56. Yu R.K., Koerner T.A., Ando S., Yohe H.C., Prestegard J.H. High-resolution proton NMR studies of gangliosides. III. Elucidation of the structure of ganglioside GM3 lactone. J. Biochem. 98:1985;1367-1373.
57. Zaleska M.M., Erecinska M. Involvement of sialic acid in high-affinity uptake of dopamine by synaptosomes from rat brain. Neurosci. Lett. 82:1987;107-112.